Sonic Healthcare Limited
Sonic Healthcare Limited SKHCF Peers
See (SKHCF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SKHCF | $18.26 | +0.00% | 8.8B | 25.01 | $0.73 | +3.84% |
| LZAGY | $70.21 | -1.34% | 50.7B | 63.33 | $1.11 | +0.59% |
| LZAGF | $705.45 | -1.23% | 49.2B | 64.96 | $11.09 | +0.34% |
| WUXAY | $10.00 | -1.48% | 28.1B | 18.52 | $0.54 | +3.22% |
| WUXIF | $7.34 | +0.00% | 20.1B | 13.59 | $0.54 | +0.25% |
| BMXMF | $142.45 | +0.00% | 16.8B | 33.76 | $4.22 | +0.73% |
| ERFSF | $71.01 | -3.77% | 12.5B | 29.59 | $2.40 | +0.97% |
| SKHHY | $17.77 | +0.45% | 8.5B | 23.97 | $0.74 | +3.82% |
| DSRLF | $107.68 | +0.00% | 5.8B | 26.72 | $4.03 | +1.10% |
| HNGZY | $4.00 | +0.00% | 5.7B | 26.67 | $0.15 | +1.03% |
Stock Comparison
SKHCF vs LZAGY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, LZAGY has a market cap of 50.7B. Regarding current trading prices, SKHCF is priced at $18.26, while LZAGY trades at $70.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas LZAGY's P/E ratio is 63.33. In terms of profitability, SKHCF's ROE is +0.05%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, SKHCF is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs LZAGF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, LZAGF has a market cap of 49.2B. Regarding current trading prices, SKHCF is priced at $18.26, while LZAGF trades at $705.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas LZAGF's P/E ratio is 64.96. In terms of profitability, SKHCF's ROE is +0.05%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, SKHCF is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs WUXAY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, WUXAY has a market cap of 28.1B. Regarding current trading prices, SKHCF is priced at $18.26, while WUXAY trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas WUXAY's P/E ratio is 18.52. In terms of profitability, SKHCF's ROE is +0.05%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, SKHCF is less volatile compared to WUXAY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs WUXIF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, WUXIF has a market cap of 20.1B. Regarding current trading prices, SKHCF is priced at $18.26, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, SKHCF's ROE is +0.05%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, SKHCF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs BMXMF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, BMXMF has a market cap of 16.8B. Regarding current trading prices, SKHCF is priced at $18.26, while BMXMF trades at $142.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas BMXMF's P/E ratio is 33.76. In terms of profitability, SKHCF's ROE is +0.05%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, SKHCF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ERFSF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ERFSF has a market cap of 12.5B. Regarding current trading prices, SKHCF is priced at $18.26, while ERFSF trades at $71.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ERFSF's P/E ratio is 29.59. In terms of profitability, SKHCF's ROE is +0.05%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, SKHCF is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs SKHHY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, SKHHY has a market cap of 8.5B. Regarding current trading prices, SKHCF is priced at $18.26, while SKHHY trades at $17.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas SKHHY's P/E ratio is 23.97. In terms of profitability, SKHCF's ROE is +0.05%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, SKHCF is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs DSRLF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, DSRLF has a market cap of 5.8B. Regarding current trading prices, SKHCF is priced at $18.26, while DSRLF trades at $107.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas DSRLF's P/E ratio is 26.72. In terms of profitability, SKHCF's ROE is +0.05%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, SKHCF is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs HNGZY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, HNGZY has a market cap of 5.7B. Regarding current trading prices, SKHCF is priced at $18.26, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, SKHCF's ROE is +0.05%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, SKHCF is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs VIMGF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, VIMGF has a market cap of 2.2B. Regarding current trading prices, SKHCF is priced at $18.26, while VIMGF trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas VIMGF's P/E ratio is 85.10. In terms of profitability, SKHCF's ROE is +0.05%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, SKHCF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs MRCHF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, SKHCF is priced at $18.26, while MRCHF trades at $20.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas MRCHF's P/E ratio is 62.68. In terms of profitability, SKHCF's ROE is +0.05%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, SKHCF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs CORBF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, CORBF has a market cap of 200.9M. Regarding current trading prices, SKHCF is priced at $18.26, while CORBF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas CORBF's P/E ratio is 3.57. In terms of profitability, SKHCF's ROE is +0.05%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, SKHCF is less volatile compared to CORBF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IDGXF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, SKHCF is priced at $18.26, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, SKHCF's ROE is +0.05%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, SKHCF is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs EDTXF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, EDTXF has a market cap of 172M. Regarding current trading prices, SKHCF is priced at $18.26, while EDTXF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas EDTXF's P/E ratio is -10.05. In terms of profitability, SKHCF's ROE is +0.05%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, SKHCF is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs AMCY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, SKHCF is priced at $18.26, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas AMCY's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to AMCY's ROE of N/A. Regarding short-term risk, SKHCF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs NNGRF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, SKHCF is priced at $18.26, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, SKHCF's ROE is +0.05%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, SKHCF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs THOXF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, SKHCF is priced at $18.26, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas THOXF's P/E ratio is -14.40. In terms of profitability, SKHCF's ROE is +0.05%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, SKHCF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs DIUXF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, SKHCF is priced at $18.26, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, SKHCF's ROE is +0.05%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, SKHCF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs TIHE Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, SKHCF is priced at $18.26, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas TIHE's P/E ratio is 0.32. In terms of profitability, SKHCF's ROE is +0.05%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, SKHCF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs BIOGF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, SKHCF is priced at $18.26, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, SKHCF's ROE is +0.05%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, SKHCF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs PCNEF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, SKHCF is priced at $18.26, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, SKHCF's ROE is +0.05%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, SKHCF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs PFGTF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, SKHCF is priced at $18.26, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, SKHCF's ROE is +0.05%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, SKHCF is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs CLIFF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, SKHCF is priced at $18.26, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, SKHCF's ROE is +0.05%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, SKHCF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs BIOQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, BIOQ has a market cap of 39.6M. Regarding current trading prices, SKHCF is priced at $18.26, while BIOQ trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas BIOQ's P/E ratio is 15.86. In terms of profitability, SKHCF's ROE is +0.05%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, SKHCF is less volatile compared to BIOQ. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs SNANF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, SNANF has a market cap of 39.5M. Regarding current trading prices, SKHCF is priced at $18.26, while SNANF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas SNANF's P/E ratio is -18.23. In terms of profitability, SKHCF's ROE is +0.05%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, SKHCF is less volatile compared to SNANF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ANPCF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ANPCF has a market cap of 34.2M. Regarding current trading prices, SKHCF is priced at $18.26, while ANPCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ANPCF's P/E ratio is -1.06. In terms of profitability, SKHCF's ROE is +0.05%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, SKHCF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ANPCY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ANPCY has a market cap of 29.3M. Regarding current trading prices, SKHCF is priced at $18.26, while ANPCY trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ANPCY's P/E ratio is -1.38. In terms of profitability, SKHCF's ROE is +0.05%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, SKHCF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs PCHM Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, PCHM has a market cap of 22.9M. Regarding current trading prices, SKHCF is priced at $18.26, while PCHM trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas PCHM's P/E ratio is -0.02. In terms of profitability, SKHCF's ROE is +0.05%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, SKHCF is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IMMVF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, SKHCF is priced at $18.26, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, SKHCF's ROE is +0.05%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, SKHCF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs VILGF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, SKHCF is priced at $18.26, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas VILGF's P/E ratio is -0.30. In terms of profitability, SKHCF's ROE is +0.05%, compared to VILGF's ROE of N/A. Regarding short-term risk, SKHCF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs LDXHF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, LDXHF has a market cap of 20.2M. Regarding current trading prices, SKHCF is priced at $18.26, while LDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas LDXHF's P/E ratio is -2.70. In terms of profitability, SKHCF's ROE is +0.05%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, SKHCF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs BMKDF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, BMKDF has a market cap of 18.5M. Regarding current trading prices, SKHCF is priced at $18.26, while BMKDF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas BMKDF's P/E ratio is -20.34. In terms of profitability, SKHCF's ROE is +0.05%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, SKHCF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ABDXF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, SKHCF is priced at $18.26, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, SKHCF's ROE is +0.05%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, SKHCF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs PMSNF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, PMSNF has a market cap of 11.8M. Regarding current trading prices, SKHCF is priced at $18.26, while PMSNF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas PMSNF's P/E ratio is -2.00. In terms of profitability, SKHCF's ROE is +0.05%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, SKHCF is less volatile compared to PMSNF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IZOZF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IZOZF has a market cap of 10.6M. Regarding current trading prices, SKHCF is priced at $18.26, while IZOZF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IZOZF's P/E ratio is -5.84. In terms of profitability, SKHCF's ROE is +0.05%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, SKHCF is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs MXDHF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, SKHCF is priced at $18.26, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, SKHCF's ROE is +0.05%, compared to MXDHF's ROE of -5.35%. Regarding short-term risk, SKHCF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs TDSGF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, TDSGF has a market cap of 8M. Regarding current trading prices, SKHCF is priced at $18.26, while TDSGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas TDSGF's P/E ratio is -3.98. In terms of profitability, SKHCF's ROE is +0.05%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, SKHCF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs VRCDF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, SKHCF is priced at $18.26, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, SKHCF's ROE is +0.05%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, SKHCF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs SQIDF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, SKHCF is priced at $18.26, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, SKHCF's ROE is +0.05%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, SKHCF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs SLDX Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, SLDX has a market cap of 4.5M. Regarding current trading prices, SKHCF is priced at $18.26, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas SLDX's P/E ratio is -0.01. In terms of profitability, SKHCF's ROE is +0.05%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, SKHCF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs JMPHF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, SKHCF is priced at $18.26, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, SKHCF's ROE is +0.05%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, SKHCF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs GNTLF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, SKHCF is priced at $18.26, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, SKHCF's ROE is +0.05%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, SKHCF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IDXG Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IDXG has a market cap of 3.3M. Regarding current trading prices, SKHCF is priced at $18.26, while IDXG trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IDXG's P/E ratio is 2.70. In terms of profitability, SKHCF's ROE is +0.05%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, SKHCF is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs AVCRF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, AVCRF has a market cap of 3.3M. Regarding current trading prices, SKHCF is priced at $18.26, while AVCRF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas AVCRF's P/E ratio is -3.26. In terms of profitability, SKHCF's ROE is +0.05%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, SKHCF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs SZLSF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, SZLSF has a market cap of 2.8M. Regarding current trading prices, SKHCF is priced at $18.26, while SZLSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas SZLSF's P/E ratio is -0.19. In terms of profitability, SKHCF's ROE is +0.05%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, SKHCF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ICBU Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ICBU has a market cap of 2.5M. Regarding current trading prices, SKHCF is priced at $18.26, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ICBU's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, SKHCF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IBXXF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, SKHCF is priced at $18.26, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, SKHCF's ROE is +0.05%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, SKHCF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IVRO Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IVRO has a market cap of 1.5M. Regarding current trading prices, SKHCF is priced at $18.26, while IVRO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IVRO's P/E ratio is -0.81. In terms of profitability, SKHCF's ROE is +0.05%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, SKHCF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs DIGP Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, SKHCF is priced at $18.26, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas DIGP's P/E ratio is -1.04. In terms of profitability, SKHCF's ROE is +0.05%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, SKHCF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs NSTM Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, NSTM has a market cap of 1.1M. Regarding current trading prices, SKHCF is priced at $18.26, while NSTM trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas NSTM's P/E ratio is -0.38. In terms of profitability, SKHCF's ROE is +0.05%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, SKHCF is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs SCRSF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, SCRSF has a market cap of 903.9K. Regarding current trading prices, SKHCF is priced at $18.26, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, SKHCF's ROE is +0.05%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, SKHCF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IDTA Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IDTA has a market cap of 874.2K. Regarding current trading prices, SKHCF is priced at $18.26, while IDTA trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IDTA's P/E ratio is 2.16. In terms of profitability, SKHCF's ROE is +0.05%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, SKHCF is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs RSHN Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, SKHCF is priced at $18.26, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas RSHN's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, SKHCF is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs EPGNF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, SKHCF is priced at $18.26, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, SKHCF's ROE is +0.05%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, SKHCF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs MBGNF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, SKHCF is priced at $18.26, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, SKHCF's ROE is +0.05%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, SKHCF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs NVTAQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, SKHCF is priced at $18.26, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, SKHCF's ROE is +0.05%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ARYC Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, SKHCF is priced at $18.26, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ARYC's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, SKHCF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs HCLC Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, SKHCF is priced at $18.26, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas HCLC's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, SKHCF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs MEDVF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, SKHCF is priced at $18.26, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, SKHCF's ROE is +0.05%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, SKHCF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs RNVA Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, RNVA has a market cap of 43.1K. Regarding current trading prices, SKHCF is priced at $18.26, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas RNVA's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, SKHCF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs CHHL Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, SKHCF is priced at $18.26, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas CHHL's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs IHTI Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, SKHCF is priced at $18.26, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas IHTI's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs MEDD Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, SKHCF is priced at $18.26, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas MEDD's P/E ratio is -0.01. In terms of profitability, SKHCF's ROE is +0.05%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, SKHCF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs CGNH Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, SKHCF is priced at $18.26, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas CGNH's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, SKHCF is less volatile compared to CGNH. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ABMC Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, SKHCF is priced at $18.26, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ABMC's P/E ratio is 0.01. In terms of profitability, SKHCF's ROE is +0.05%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, SKHCF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs RGDXQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, SKHCF is priced at $18.26, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, SKHCF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs DMTKQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, SKHCF is priced at $18.26, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, SKHCF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs TOMDF Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, TOMDF has a market cap of 1.4K. Regarding current trading prices, SKHCF is priced at $18.26, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas TOMDF's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, SKHCF is more volatile compared to TOMDF. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs GWHP Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, SKHCF is priced at $18.26, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas GWHP's P/E ratio is -0.00. In terms of profitability, SKHCF's ROE is +0.05%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs CYPS Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, CYPS has a market cap of 811. Regarding current trading prices, SKHCF is priced at $18.26, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas CYPS's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to CYPS's ROE of N/A. Regarding short-term risk, SKHCF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs ROSGQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, SKHCF is priced at $18.26, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, SKHCF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs BIOCQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, SKHCF is priced at $18.26, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, SKHCF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs HTGMQ Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, SKHCF is priced at $18.26, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, SKHCF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs OPGX Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, OPGX has a market cap of 17. Regarding current trading prices, SKHCF is priced at $18.26, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas OPGX's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, SKHCF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs AGHC Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, AGHC has a market cap of 0. Regarding current trading prices, SKHCF is priced at $18.26, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas AGHC's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, SKHCF is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs MRPS Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, MRPS has a market cap of 0. Regarding current trading prices, SKHCF is priced at $18.26, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas MRPS's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to MRPS's ROE of N/A. Regarding short-term risk, SKHCF is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs BGNX Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, BGNX has a market cap of 0. Regarding current trading prices, SKHCF is priced at $18.26, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas BGNX's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.05%, compared to BGNX's ROE of N/A. Regarding short-term risk, SKHCF is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.
SKHCF vs EPGNY Comparison
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 8.8B. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, SKHCF is priced at $18.26, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 25.01, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, SKHCF's ROE is +0.05%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, SKHCF is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for SKHCF.